Taconic Capital Advisors’s Verona Pharma VRNA Stock Holding History

Taconic Capital Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-232,930	Closed	-$24.9M	–	49
2025 Q3	$24.9M	Buy	+232,930	New	+$24.3M	5.74%	6

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Taconic Capital Advisors's VRNA Position: Q4 2025 in Review

Taconic Capital Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 232,930 shares — an estimated $24.9M sold.

Taconic Capital Advisors first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $24.9M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Taconic Capital Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Taconic Capital Advisors sold 232,930 Verona Pharma shares in Q4 2025, an estimated $24.9M.
Taconic Capital Advisors first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Taconic Capital Advisors's Verona Pharma position peaked at $24.9M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Taconic Capital Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.